Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in TBPH — Theravance Biopharma, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to TBPH Full portfolio

Position in TBPH

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$697,170
+$181,820 QoQ
Shares Held
41,010
+29.2% QoQ
Ownership
0.079%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 1% Shared 0% None 99%

Common Shares in TBPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. TBPH ranks #163 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in TBPH

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $697,170 41,010
2026-03-31 $515,350 31,753
2025-12-31 $506,535 27,073
2025-09-30 $374,504 25,651
2025-06-30 $282,930 25,651
2025-03-31 $225,509 25,253
2024-12-31 $438,035 46,550
2024-09-30 $249,392 30,942
2024-06-30 $187,077 22,061
2024-03-31 $249,653 27,832
2023-12-31 $307,964 27,399
2023-09-30 $242,804 28,135
2023-06-30 $248,368 23,997
2023-03-31 $519,584 47,888
2022-12-31 $470,779 41,959
2022-09-30 $304,838 30,063
2022-06-30 $367,598 40,574
2022-03-31 $405,017 42,366
2021-12-31 $506,851 45,869
2021-09-30 $296,746 40,101
2021-06-30 $540,695 37,238
2021-03-31 $4,169,476 204,286
2020-12-31 $3,820,033 214,971
2020-09-30 $3,869,854 261,742
2020-06-30 $10,117,619 482,021
2020-03-31 $11,009,279 476,386